FDA approves aminolevulinic acid hydrochloride as an optical imaging agent indicated in patients with gliomas

21st June 2017 Uncategorised 0

European Society for Medical Oncology News

More: FDA approves aminolevulinic acid hydrochloride as an optical imaging agent indicated in patients with gliomas
Source: MDlinx